Melatoninergic Pathways in Alzheimer's Disease
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
3-49
Author(s):
George Anderson and Michael Maes
Nanomedicine Based Drug Targeting in Alzheimer’s Disease: High Impact of Small Carter
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
716-739
Author(s):
Mohammad Zaki Ahmad, Sohail Akhter, Ziyaur Rahman, Javed Ahmad, Iqbal Ahmad and Farhan Jalees Ahmad
Targeting the GSK3β/β-catenin Signaling to Treat Alzheimer´s Disease: Plausible or Utopic?
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
623-642
Author(s):
Fares Zeidán-Chuliá and José Cláudio Fonseca Moreira
Neprilysin Inhibitors Provide Insight into its Specificity and Therapeutic Potential
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
598-622
Author(s):
Darrick Pope and Michael Cascio
Somatostatin Receptor-4 Agonists as Candidates for Treatment of Alzheimer’s Disease
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
566-597
Author(s):
Karin E. Sandoval, Kenneth A. Witt, A. Michael Crider and Maria Kontoyianni
Combining BACE1 Inhibition with Metal Chelation as Possible Therapy for Alzheimer’s Disease
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
547-565
Author(s):
Maged M. Henary, Tyler L. Dost, Eric A. Owens and Surendra Reddy Punganuru
BACE1 Inhibitors: Attractive Therapeutics for Alzheimer’s Disease
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
518-546
Author(s):
Boris Decourt, MiMi Macias, Marwan Sabbagh and Abdu Adem
Role of Acetylcholinesterase Inhibitors and Alzheimer Disease
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
387-425
Author(s):
Zafar Saied Saify and Nighat Sultana
Specific Cholinesterase Inhibitors: A Potential Tool to Assist in Management of Alzheimer Disease
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
366-386
Author(s):
Nigel H. Grieg, Mohammad A. Kamal, Nasimudeen R. Jabir, Shams Tabrez, Faizul H. Nasim, Adel M. Abuzenadah and Gjumrakch Aliev
Enzyme Inhibitors Involved in the Treatment of Alzheimer’s Disease
Book:
Drug Design and Discovery in Alzheimer's Disease
Page:
142-198
Author(s):
Vageesh Revadigar, Raza Murad Ghalib, Vikneswaran Murugaiyah, Mohamed A. Embaby, Ali Jawad, Sayed Hasan Mehdi, Rokiah Hashim and Othman Sulaiman